文献速递糖尿病肥胖与代谢综合征

高血糖成人尿硝酸盐与糖尿病并发症及疾病特异性死亡率的关联

Association of Urinary Nitrate With Diabetes Complication and Disease-Specific Mortality Among Adults With Hyperglycemia.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究纳入2005至2014年美国国家健康与营养调查中6208例高血糖成人,采用logistic回归和Cox比例风险模型分析尿硝酸盐与糖尿病并发症及死亡率的关联。尿硝酸盐最高三分位组较低三分位组充血性心力衰竭和糖尿病肾病风险更低,全因、心血管疾病和糖尿病死亡率也更低,且呈剂量依赖线性关系。

要点

  • 尿硝酸盐最高三分位组较低三分位组充血性心力衰竭风险更低(OR 0.41;95%CI,0.27-0.60)。
  • 尿硝酸盐最高三分位组较低三分位组糖尿病肾病风险更低(OR 0.50;95%CI,0.41-0.62)。
  • 尿硝酸盐最高三分位组全因、心血管疾病和糖尿病死亡率更低,癌症死亡率无显著关联。

核心结论

  • 较高的尿硝酸盐与充血性心力衰竭和糖尿病肾病风险降低相关,也与全因、心血管疾病和糖尿病死亡率降低相关。
  • 作者认为无机硝酸盐补充可考虑作为高血糖人群的辅助治疗。

研究设计与样本

  • 研究纳入2005至2014年美国国家健康与营养调查中6208例高血糖参与者。
  • 采用logistic回归模型和Cox比例风险模型分别评估尿硝酸盐与糖尿病并发症风险及疾病特异性死亡率的关联。
  • 尿硝酸盐采用离子色谱-电喷雾串联质谱法测定,经对数转换后按三分位分组。

主要发现

  • 调整潜在混杂因素(包括尿高氯酸盐和硫氰酸盐)后,尿硝酸盐最高三分位组较低三分位组充血性心力衰竭风险更低(OR 0.41;95%CI,0.27-0.60)。
  • 尿硝酸盐最高三分位组较低三分位组糖尿病肾病风险更低(OR 0.50;95%CI,0.41-0.62)。
  • 在总计41463人年的随访期间,尿硝酸盐最高三分位组较低三分位组全因死亡率更低(HR 0.78;95%CI,0.62-0.97)。
  • 尿硝酸盐最高三分位组较低三分位组心血管疾病死亡率更低(HR 0.56;95%CI,0.37-0.84)。
  • 尿硝酸盐最高三分位组较低三分位组糖尿病死亡率更低(HR 0.47;95%CI,0.24-0.90),呈剂量依赖线性关系(非线性检验P > 0.05)。

临床怎么用

  • 作者认为无机硝酸盐补充可考虑作为高血糖人群的辅助治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The hyperglycemia condition disrupts metabolism of nitrate/nitrite and nitric oxide, and dietary nitrate intake can restore nitric oxide homeostasis. OBJECTIVE: This study aims to examine whether urinary nitrate is associated with diabetes complications and long-term survival among people with hyperglycemia. METHODS: A total of 6208 people with hyperglycemia who participated in the National Health and Nutrition Examination Survey from 2005 to 2014 were enrolled. Diabetes complications included congestive heart failure, coronary heart disease, angina, stroke, myocardial infarction, diabetic retinopathy, and nephropathy. Mortality was obtained from the National Death Index until 2015. Urinary nitrate was measured by ion chromatography coupled with electrospray tandem mass spectrometry, which was log-transformed and categorized into tertiles. Logistic regression models and Cox proportional hazards models were respectively performed to assess the association of urinary nitrate with the risk of diabetes complications and disease-specific mortalities. RESULTS: After adjustment for potential confounders, including urinary perchlorate and thiocyanate, compared with the participants in the lowest tertile of nitrate, the participants in the highest tertile had lower risks of congestive heart failure (odds ratio [OR] 0.41; 95% CI, 0.27-0.60) and diabetic nephropathy (OR 0.50; 95% CI, 0.41-0.62). Meanwhile, during a total follow-up period of 41 463 person-years, the participants in the highest tertile had lower mortality risk of all-cause (hazard ratio [HR] 0.78; 95% CI, 0.62-0.97), cardiovascular disease (CVD) (HR 0.56; 95% CI, 0.37-0.84), and diabetes (HR 0.47; 95% CI, 0.24-0.90), which showed dose-dependent linear relationships (P for nonlinearity > 0.05). Moreover, no association between nitrate and cancer mortality was observed (HR 1.13; 95% CI, 0.71-1.80). CONCLUSION: Higher urinary nitrate is associated with lower risk of congestive heart failure and diabetic nephropathy, and lower risk of all-cause, CVD, and diabetes mortalities. These findings indicate that inorganic nitrate supplementation can be considered as a supplementary treatment for people with hyperglycemia.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jiang W, Zhang J, Yang R, et al. Association of Urinary Nitrate With Diabetes Complication and Disease-Specific Mortality Among Adults With Hyperglycemia. J Clin Endocrinol Metab. 2023. PMID: 36576885. doi:10.1210/clinem/dgac741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。